European Commission Names Drugs That Won't Need EU 'Safety Feature'
This article was originally published in SRA
Executive Summary
The European Commission has set out the fine detail of the "unique identifier" that in future will have to be affixed to the packaging of practically all prescription medicines marketed in Europe, as required by the EU's directive on falsified medicines1.
You may also be interested in...
EU Updates Guidance On Safety Features For Drugs Under Falsified Medicines Directive
The EU has issued updated guidance on the Falsified Medicines Directive, which gives drug manufacturers until February 2019 to affix 2D barcodes on their products to allow the identification and authentication of individual packs.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.